Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Preferred shares
Common shares
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Balance at beginning of period (shares) at Dec. 31, 2019   11 55,212      
Balance at beginning of period at Dec. 31, 2019 $ 51,352   $ 55 $ 227,468 $ (1,995) $ (174,176)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (3,597)         (3,597)
Foreign currency translation adjustment 652       652  
Unrealized gain on investments 116       116  
Stock based compensation expense 1,283     1,283    
Balance at end of period (shares) at Mar. 31, 2020   11 55,212      
Balance at end of period at Mar. 31, 2020 49,806   $ 55 228,751 (1,227) (177,773)
Balance at beginning of period (shares) at Dec. 31, 2020   14 56,003      
Balance at beginning of period at Dec. 31, 2020 31,027   $ 56 242,672 (295) (211,406)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (4,172)         (4,172)
Foreign currency translation adjustment 489       489  
Stock based compensation expense 1,199     1,199    
Issuance of common stock resulting from exercise of stock options 20     20    
Issuance of common stock resulting from exercise of stock options (in shares)     10      
Issuance of common stock pursuant to private placement offering 9,673   $ 4 9,669    
Issuance of common stock pursuant to private placement offering (in shares)     3,706      
Balance at end of period (shares) at Mar. 31, 2021   14 59,719      
Balance at end of period at Mar. 31, 2021 $ 38,236   $ 60 $ 253,560 $ 194 $ (215,578)